1.24

0.81% 0.01

Actinium Pharmaceuticals Inc (ATNM)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.23

Offen:

$1.24

24-Stunden-Volumen:

258.72K

Relative Volume:

1.89

Marktkapitalisierung:

$39.06M

Einnahmen:

$90,000

Nettoeinkommen (Verlust:

$-23.47M

KGV:

-1.6485

EPS:

-0.7522

Netto-Cashflow:

$-22.98M

1W Leistung:

+24.00%

1M Leistung:

+55.51%

6M Leistung:

+3.33%

1J Leistung:

-22.50%

1-Tages-Spanne:

$1.2301

$1.305

1-Wochen-Bereich:

$1.01

$1.305

52-Wochen-Spanne:

$0.7351

$1.74

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Firmenname

Actinium Pharmaceuticals Inc

Sektor

Healthcare (1087)

Branche

Biotechnology (606)

Telefon

646-767-3870

Adresse

275 Madison Avenue, 7th Floor, New York, NY

Mitarbeiter

Twitter

@actiniumpharma

Nächster Verdiensttermin

2026-08-14

Neueste SEC-Einreichungen

ATNM's Discussions on Twitter

Compare ATNM vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ATNM Actinium Pharmaceuticals Inc	1.245	38.59M	90,000	-23.47M	-22.98M	-0.7522
VRTX Vertex Pharmaceuticals Inc	520.95	134.06B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.06	83.43B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,005.68	63.00B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	137.24	56.02B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.87	44.44B	742.00K	-1.37B	-1.07B	-7.0731

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-07	Herabstufung	B. Riley Securities	Buy → Neutral
2024-05-14	Eingeleitet	Stephens	Overweight
2023-09-06	Eingeleitet	HSBC Securities	Buy
2023-02-21	Herabstufung	William Blair	Outperform → Mkt Perform
2022-09-08	Eingeleitet	Cantor Fitzgerald	Overweight
2022-08-25	Eingeleitet	B. Riley Securities	Buy
2020-11-05	Eingeleitet	Alliance Global Partners	Buy
2017-12-06	Eingeleitet	B. Riley FBR, Inc.	Buy
2017-10-23	Fortgesetzt	ROTH Capital	Buy
2017-09-14	Eingeleitet	Maxim Group	Buy
2016-08-25	Eingeleitet	ROTH Capital	Buy
2016-02-29	Eingeleitet	H.C. Wainwright	Buy
2015-10-15	Eingeleitet	FBR Capital	Outperform
2014-10-01	Eingeleitet	MLV & Co	Buy
2014-07-22	Eingeleitet	Canaccord Genuity	Buy

Alle ansehen

Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten

Sep 04, 2026

Actinium CEO to present at H.C. Wainwright Glob... - Pluang

Sep 04, 2026

Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire

Sep 04, 2026

Actinium Pharmaceuticals (ATNM) grants director new stock awards - Stock Titan

Sep 04, 2026

Actinium Pharmaceuticals (ATNM) grants director $1.00 options and RSUs - Stock Titan

Sep 04, 2026

Aug 23, 2026

Actinium (ATNM) Update: Slides 1.79% to $1.10 in Latest Trading; Next Test: Traders Can Monitor the $1.04-$1.16 Range in the Latest SessionBreakout Confirmation - vinanet.vn

Aug 23, 2026

Aug 19, 2026

Actinium (ATNM) Chart: Ends Up by 3.24% at $1.11 in Latest Trading; Level Watch: the Supplied Trading Band Runs From $1.05 to $1.17Up Down Ratio - vinanet.vn

Aug 19, 2026

KPTI Stock Price and Chart — NASDAQ:KPTI - TradingView

Aug 19, 2026

ETFs Investing in Actinium Pharmaceuticals, Inc. Stocks - TradingView

Aug 19, 2026

Aug 15, 2026

Analysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Pyxis Oncology (PYXS) - The Globe and Mail

Aug 15, 2026

Aug 14, 2026

Form 8K Actinium Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Nigeria

Aug 14, 2026

Actinium Pharmaceuticals Announces Actimab-A Intellectual Property And Manufacturing Advances And Provides NYSE American Listing Update - TradingView

Aug 14, 2026

Actinium Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Aug 14, 2026

Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update - PR Newswire

Aug 14, 2026

Aug 12, 2026

Actinium Pharmaceuticals (ATNM) Institutional Ownership 2026 - MarketBeat

Aug 12, 2026

Aug 10, 2026

Actinium Pharmaceuticals (ATNM) Slips 3.4% to $0.77 as Key Support at $0.73 Comes into FocusInstitutional Sentiment - dars.gov.et

Aug 10, 2026

Aug 05, 2026

Actinium Pharmaceuticals (ATNM) Falls 7.5% to $0.75 as Selling Pressure IntensifiesGrowth ETF - dars.gov.et

Aug 05, 2026

Aug 03, 2026

Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. (ATNM) InvestorsLead Plaintiff Deadline on May 27, 2025 - The National Law Review

Aug 03, 2026

Aug 01, 2026

Actinium Pharmaceuticals, Inc. (Delaware) Revenue Breakdown – AMEX:ATNM - TradingView

Aug 01, 2026

Jul 28, 2026

Actinium Pharmaceuticals (ATNM) Edges Higher as Stock Holds Above Key SupportInitial Balance - dars.gov.et

Jul 28, 2026

Jul 27, 2026

Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM)Join by May 27, 2025Contact Levi & Korsinsky - The National Law Review

Jul 27, 2026

Jul 26, 2026